4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465826-14-000003
Chief Scientific Officer sold 1,824,500 shares at an average $0.77 ($1,407,330)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NIGALAYE ASHOK G Chief Scientific Officer | 2014-03-06 | Sale | −773,050 | $0.90 | $692,344 | 20,688,015 | I |
| NIGALAYE ASHOK G Chief Scientific Officer | 2014-03-07 | Sale | −1,051,450 | $0.68 | $714,986 | 20,372,580 | I |
| Open-market sales · 1,824,500 sh · avg $0.77 · $1,407,330 | |||||||
Loading xslF345X03/primary_doc.xml…